Zosano Pharma (NASDAQ: ZSAN): Buy With Price Target=$12

ZSAN

Zosano Pharma (ZSAN) is an emerging lifesciences company that is developing novel treatments for diseases using its proprietary transdermal delivery platform. The company's stock has been on a tear for the past week after announcing successful phase 3 results of M207, its transdermal patch for th...

Zosano Pharma (ZSAN) is an emerging lifesciences company that is developing novel treatments for diseases using its proprietary transdermal delivery platform. The company's stock has been on a tear for the past week after announcing successful phase 3 results of M207, its transdermal patch for th...

This article is only available to subscribers of Vasuda Healthcare Analytics
Learn more about Vasuda Healthcare Analytics